Lysophosphatidic Acid Promotes Epithelial–Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy

• Published in: International journal of molecular sciences Vol. 23; no. 18; p. 10497
• Main Authors: Lee, Geon-Ho, Cheon, Jayeon, Kim, Donghee, Jun, Hee-Sook
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 10-09-2022; MDPI
• Subjects: Actin; AKT protein; Apoptosis; c-Jun protein; Cell cycle; Cell growth; Diabetes; Diabetes mellitus; Diabetic nephropathy; E-cadherin; Epithelial cells; epithelial–mesenchymal transition; Epithelium; Extracellular signal-regulated kinase; Fibronectin; Fibrosis; Growth factors; JNK protein; Kidneys; Kinases; Krüppel-like factor 5; Lysophosphatidic acid; lysophosphatidic acid receptor 1; MAP kinase; Markers; Mesenchyme; Morphology; Muscles; Nephropathy; Pathogenesis; Phosphorylation; Protein-serine/threonine kinase; Proteins; Rodents; Signal transduction; Smooth muscle; Transcription factors; Tubules; Vimentin
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms231810497

The epithelial–mesenchymal transition (EMT) is a differentiation process associated with fibrogenesis in diabetic nephropathy (DN). Lysophosphatidic acid (LPA) is a small, naturally occurring glycerophospholipid implicated in the pathogenesis of DN. In this study, we investigated the role of LPA/LPAR1 signaling in the EMT of tubular cells as well as the underlying mechanisms. We observed a decrease in E-cadherin and an increase in vimentin expression levels in the kidney tubules of diabetic db/db mice, and treatment with ki16425 (LPAR1/3 inhibitor) inhibited the expression of these EMT markers. Ki16425 treatment also decreased the expression levels of the fibrotic factors fibronectin and alpha-smooth muscle actin (α-SMA) in db/db mice. Similarly, we found that LPA decreased E-cadherin expression and increased vimentin expression in HK-2 cells, which was reversed by treatment with ki16425 or AM095 (LPAR1 inhibitor). In addition, the expression levels of fibronectin and α-SMA were increased by LPA, and this effect was reversed by treatment with ki16425 and AM095 or by LPAR1 knockdown. Moreover, LPA induced the expression of the transcription factor, Krüppel-like factor 5 (KLF5), which was decreased by AM095 treatment or LPAR1 knockdown. The expression levels of EMT markers and fibrotic factors induced by LPA were decreased upon KLF5 knockdown in HK-2 cells. Inhibition of the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and serine-threonine kinase (AKT) pathways decreased LPA-induced expression of KLF5 and EMT markers. In conclusion, these data suggest that LPA contributes to the pathogenesis of diabetic nephropathy by inducing EMT and renal tubular fibrosis via regulation of KLF5 through the LPAR1.